We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Stroke following zoledronic acid infusion: effect of treatment or coincidence?
- Authors
Erol, Asiye Mukaddes; Çelik, Canan; Yalbuzdağ, Seniz Akçay; Şentürk, Burcu
- Abstract
Zoledronic acid is a parenteral aminobisphosphonate which is administered annually in the treatment of osteoporosis. It is an alternative to oral bisphosphonates, particularly in elderly patients with multiple comorbidities, because of its efficacy and intravenous route of administration. The most common side effects include post-dose reaction, renal dysfunction, and mild to moderate hypocalcemia. In this article, we report a 67-year-old male case of stroke during osteoporosis treatment of zoledronic acid within a day. Stroke development may be a coincidence, as the patient had stroke history and other risk factors for recurrent stroke. This case report highlights the possibility of zoledronic acid infusion-induced stroke with unusual side effects in geriatric patients.
- Publication
Turkish Journal of Physical Medicine & Rehabilitation / Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi, 2016, Vol 62, Issue 2, p170
- ISSN
1302-0234
- Publication type
Article
- DOI
10.5152/tftrd.2015.98475